BRPI1012108A2
(en )
2016-03-29
3- [4- (7h-pyrrolo [2,3-d] pyrimidin-4-yl) -1h-pyrazol-1-yl] octane- or heptane-nitrile as jak inhibitors
DK2878598T3
(en )
2019-08-12
Crystalline Form of 4- [5- (PYRIDIN-4-YL) -1H-1,2,4-TRIAZOL-3-YL] PYRIDIN-2-CARBONITRIL
BRPI0921022A2
(en )
2015-12-29
pirfenidone treatment for patients with atypical liver function
BR112013023277A2
(en )
2017-06-27
Cancer treatment methods using 3- (5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl) -piperidibna-2,6-dione
DK2882442T3
(en )
2021-08-16
PROCEDURES FOR THE TREATMENT OF CANCER USING 3- (4 - ((4- (MORPHOLINOMETHYL) BENZYL) OXY) -1-OXOISOINDOLIN-2-YL) PIPERIDINE-2,6-DION
EP2545058A4
(en )
2013-07-24
Heterocyclic inhibitors of histamine receptors for the treatment of disease
DK3686193T3
(en )
2022-05-30
2- (2,4,5-SUBSTITUTED ANILINO) PYRIMIDINE COMPOUNDS
IT1400425B1
(en )
2013-05-31
MODIFIED SNRNAS FOR USE IN THERAPY.
BRPI0822722A2
(en )
2015-07-07
Implement for oral care.
BRPI0906802A2
(en )
2015-07-14
Implement for oral care.
BR112013004409A8
(en )
2018-07-10
container for storing personal care articles.
IT1390737B1
(en )
2011-09-23
MACHINE FOR THE CONSTRUCTION OF ABSORBENT ITEMS.
BRPI0913873A2
(en )
2015-10-27
single dose container
IT1391866B1
(en )
2012-01-27
INJECTIONABLE COMPOSITION OF POLYNUCLEOTIDS FOR THE TREATMENT OF OSTEOARTICULAR DISEASES.
BRPI0907916A2
(en )
2015-07-28
Spirocycle heterocycles, medicaments containing such compounds, and processes for preparing them
BR112012016786A2
(en )
2015-09-01
Processes for preparing 7-methyl-5- (3-piperazin-1-ylmethyl- [1,2,4] oxadiazol-5-yl) -2- (4-trifluoromethoxybenzyl) -2
SMT201500166B
(en )
2015-09-07
1,2,4-triazolone derivative
SMT201600421B
(en )
2017-01-10
7-METHYL-2- [4-METHYL-6- [4- (trifluoromethyl) phenyl] pyrimidin-2-IL] -1,7-diazaspiro [4.4] nonan-6-ONE
HK1210969A1
(en )
2016-05-13
Substituted heterocyclic compounds for disease treatment
SI2608789T1
(en )
2017-06-30
Therapeutic uses of 1-(2-(2,4-dimethyl-phenylsulfanyl)phenyl)piperazine
EP2891483A4
(en )
2016-05-04
Pharmaceutical composition for treating gastro-oesophageal reflux disease
ES2388389B1
(en )
2013-09-03
PROCEDURE FOR MANAGING THE CONVERGENT ADDRESS BOOK CAPACITY.
IT1400886B1
(en )
2013-07-02
INFUSER GROUP.
PL395738A1
(en )
2013-02-04
New medical use for 4- (n-butyl) -5- (3-chlorophenyl) -2,4-dihydro-3H-1,2,4-triazole-3-thione
IL228891A
(en )
2015-11-30
3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts for use in the treatment of cardiovascular disease